Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Outsourcing Facilities Need More Regulatory Transparency From FDA To Compound Drugs In Shortage
Jul 02 2020
•
By
Joanne S. Eglovitch
Report Cites Reasons Why Outsourcing Facilities Not Compounding Drugs In Shortage • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Manufacturing
More from Compliance